Danny Moore

Strategic Account Director, UK Novartis

Danny Moore, the UK Field Market Access Director at Novartis, brings over 25 years of pharmaceutical industry experience. He is dedicated to enhancing patient outcomes through collaboration with the NHS. Danny was a member of the Lipid Management Programme Board, chairing the Lipid Management Delivery Oversight Group as part of the NHSE/AAC tri-partite programme. His expertise spans innovative medicine launches, strategic partnerships, and operational delivery.

Pharma Launch Excellence Summit Main Conference Day 1: Tuesday 3rd December

11:30 AM Roundtable Discussion: Health System and Market Strengthening: Alignment, Partnering and Integration for Launch Readiness

Setting the scene: The Centrality of Partnerships for Launch readiness  5 min

Chair : Troels Sørensen - Global Head Clinical Practice, Boehringer Ingelheim


Talk 1 : Target Population Outputs (TPOs) – is the market leady for launch? 7 min

Troels Sørensen – Head of Global Clinical Practice, Boehringer Ingelheim


Talk 2 : Evidence is the product – is the product launch ready ? 7 min

Laura Wallace – Head of Global Integrated Evidence - Boehringer Ingelheim

 

Talk 3: Engagement and Strategic PPPs at government level: market shaping for launch and uptake of innovations 7 min

Lena Lymperopoulou - Global Policy Executive, ex Novartis / GSK. Founder of the World Economic Forum Strategic PPPs initiative

 

Talk 4: Partnerships at health body and regional level: Access and launch readiness 7 min

Danny Moore  - Strategic Account Director – Novartis

 

Talk 5: Partnerships at departmental level: Transforming Field medical to impact accountable launch leaders 7 min

Helen Kane – Global Medical Affairs and Field Medical Affairs Executive - ex-Novarts/Roche/Celgene. Founder of One MSL.


Panel discussion and questions 20 min

·       Focus on the capabilities required by each respective function

Check out the incredible speaker line-up to see who will be joining Danny.

Download The Latest Agenda